REGENERON ANNOUNCES SETTLEMENT OF PATENT LITIGATION WITH GENENTECH FOR US OPHTHALMIC SALES OF EYLEA AFLIBERCEPT

January 3, 2012

TARRYTOWN, N.Y , Jan. 3, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN - News) today announced that the Company has entered into a non-exclusive license and partial settlement agreement (Agreement) ...

Full Story Below

Rapid Response
Free Case Evaluation

The Help You Need,
When You Need it Most

Area of Law
First Name
Last Name
Phone
Email
Zip Code
Case Specifics
Please Type The Number You See Below
8828

More from Settlement News Directory

lawyercen

Settlement in Spokane boys39 home lawsuits..

lawyercen

Court OKs 110M JPMorgan overdraft settlement..

lawyercen

In lawsuit settlement Jackson Miss schools agree to stop handcuffing studen..

lawyercen

ASC reaches illegal insider trading settlement with Edward Twanow..

lawyercen

Should States Be Chided for How They Use Their Mortgage Settlement Money..

lawyercen

Settlement of Illinois lawsuit over shackles during birth..

lawyercen

Apple and Samsung fail to reach patent settlement during talks..

lawyercen

AllianceOne and Class Counsel Announce TCPA Class Action Settlement..

lawyercen

Settlement for pregnant inmates who say they were shackled..

lawyercen

AFFCO settlement welcomed..

lawyercen

Groupon Settlement How To Claim Your Part Of 85 Million In Class-Action Dam..

lawyercen

Dania axes airport runway settlement..

lawyercen

Altria Reaches 500 Million Settlement With IRS Raises Fiscal Year EPS View ..

lawyercen

Gov Brown gets backing to use settlement funds for budget gap..

lawyercen

41 million settlement for pregnant inmates who say they were shackled..

REGENERON ANNOUNCES SETTLEMENT OF PATENT LITIGATION WITH GENENTECH FOR US OPHTHALMIC SALES OF EYLEA AFLIBERCEPT

January 3, 2012

Rapid Response Free Case Evaluation

The Help You Need, When You Need it Most

8828

More from Settlement News Directory

Rapid Response
Free Case Evaluation

The Help You Need,
When You Need it Most